Young Girl Celebrates End of Cancer Treatment with Big Dreams
Imohgen Alo, a 12-year-old resident of Wangi Wangi, rang the bell at John Hunter Children's Hospital on Friday, marking the triumphant conclusion of her intense two-year battle against T-cell lymphoma, a form of blood cancer. Diagnosed at age 10 in 2024, she expressed gratitude for the medical team that supported her through this challenging journey.
Resilience and Aspirations Amid Adversity
Despite the ordeal, Imohgen has emerged with ambitious goals. "I want to continue with my sport, make the Olympics for rugby, play NRLW and hopefully become an oncology nurse so I can help kids go through their journey," she said. Her diagnosis came after a golf ball-sized lump appeared on her chest, with further tests revealing a mass as large as her father's fist.
Her father, Ray Alo, described the rapid onset of the diagnosis, noting how it felt like being in quicksand. "When we broke the news to her, her response was 'can I not play football?'" he recalled, highlighting her unwavering passion for rugby union, league, and touch football.
Treatment and Family Support
Imohgen underwent eight months of intense chemotherapy, including a port implanted in her chest, followed by maintenance treatment with daily tablets. Her mother, Stevie Alo, emphasized the family's strengthened bond and positive outlook, attributing it to Imohgen's resilience. "We have such a different outlook on life now. It's brought us all together," she said.
The Alo family praised the staff at John Hunter Hospital for their direct and honest approach, which instilled confidence during the treatment process. Imohgen's cultural background as Aboriginal has also been a significant source of strength, inspiring her to represent her heritage through sports.
Achievements and Future Prospects
Throughout her treatment, Imohgen was selected for the under-12 Hunter Wildfires rugby union team, playing at 65% body strength. This year, she made the under-14 team and started year 7 at Hunter Sports High. Her story underscores the importance of early detection and advanced treatments in pediatric cancer.
Bill Stavreski, head of research at the Leukaemia Foundation, noted that blood cancer survival rates for children have improved to about 90%, accounting for 40-50% of all childhood cancers. Research continues to focus on identifying risk factors through mutations and biomarkers to enhance early detection and outcomes.
